Skip to content

Aurigen Medical

Categories

MedTech & Pharmaceutical

About Us

AuriGen Medical is a pre-clinical MedTech company, specialising in treatment of atrial-fibrillation(AF) a devastating heart-rhythm disorder affecting 50m people worldwide. AuriGen was co-founded by Dr.John Thompson and R&D specialist Tony O?Halloran and spun-out of NUIG-BioInnovate-Fellowship in 2018. As a Doctor, John had seen many patients with advanced AF fail all existing treatments, resulting in poor quality-of-life and increased stroke-risk, heart-failure, dementia & death. The AuriGen device treats part of the upper chamber of the heart known as the left-atrial-appendage(LAA) to prevent strokes and treat abnormal electrical activity causing AF, causing AF dramatically improving patient treatment success.

Joining the Galway Chamber will offer AuriGen Medical the oportunity to connect with decision makers across a wide range of businesses and in particular the many Medtech companies already members of the Galway Chamber.

Rep/Contact Info

Ms. Julie Eyers
Director of Quality and Regulatory
Siora Maclean
Director of Operations
Mr. John Thompson (N)
CEO